Skip to main content

Table 2 Multiple reaction monitoring (MRM) transitions, compound dependent parameters, and retention times

From: Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance

Substance

Q1

Q3 quantifier

Q3 qualifier

DP

CE

Retention time (min)

Temozolomide

194.15

138.1

177.18

35

13

1.4

Panobinostat

349.43

158.1

309.22

76

22

2.5

  1. DP declustering potential, CE collision energy, Q1/Q3 first and third
Back to article page

Fluids and Barriers of the CNS

ISSN: 2045-8118